These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9704914)

  • 1. Comparison between a twin-screw extruder and a rotary ring die press. Part II: influence of process variables.
    Schmidt C; Kleinebudde P
    Eur J Pharm Biopharm; 1998 Mar; 45(2):173-9. PubMed ID: 9704914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. II. Sphere characteristics.
    Thoma K; Ziegler I
    Drug Dev Ind Pharm; 1998 May; 24(5):413-22. PubMed ID: 9876603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of plate design on the properties of pellets produced by extrusion and spheronization.
    Michie H; Podczeck F; Newton JM
    Int J Pharm; 2012 Sep; 434(1-2):175-82. PubMed ID: 22659150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. I. Extrusion behavior of formulations.
    Thoma K; Ziegler I
    Drug Dev Ind Pharm; 1998 May; 24(5):401-11. PubMed ID: 9876602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spheronization of small extrudates containing kappa-carrageenan.
    Yoo A; Kleinebudde P
    J Pharm Sci; 2009 Oct; 98(10):3776-87. PubMed ID: 19130471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extruder scale-up assessment in the process of extrusion-spheronization: comparison of radial and axial systems by a design of experiments approach.
    Désiré A; Paillard B; Bougaret J; Baron M; Couarraze G
    Drug Dev Ind Pharm; 2013 Feb; 39(2):176-85. PubMed ID: 23216219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of process variables on physical properties of the pellets using extruder and spheronizer.
    Umprayn K; Chitropas P; Amarekajorn S
    Drug Dev Ind Pharm; 1999 Jan; 25(1):45-61. PubMed ID: 10028418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures.
    Kleinebudde P; Schröder M; Schultz P; Müller BW; Waaler T; Nymo L
    Pharm Dev Technol; 1999 Aug; 4(3):397-404. PubMed ID: 10434285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM; Augsburger LL; Pope DG; Shah RD
    Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on the co-extrudability and spheronization properties of wet masses.
    Pinto JF; Lameiro MH; Martins P
    Int J Pharm; 2001 Oct; 227(1-2):71-80. PubMed ID: 11564542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheological evaluation of wet masses for the preparation of pharmaceutical pellets by capillary and rotational rheometers.
    Majidi S; Motlagh GH; Bahramian B; Kaffashi B; Nojoumi SA; Haririan I
    Pharm Dev Technol; 2013 Feb; 18(1):112-20. PubMed ID: 22188436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spheronization of solid lipid extrudates: Elucidation of spheroid formation mechanism.
    Petrovick GF; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Apr; 125():148-158. PubMed ID: 29407224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a power-consumption-controlled extruder in the development of pellet formulations.
    Kleinebudde P
    J Pharm Sci; 1995 Oct; 84(10):1259-64. PubMed ID: 8801345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A data mining approach to optimize pellets manufacturing process based on a decision tree algorithm.
    Ronowicz J; Thommes M; Kleinebudde P; Krysiński J
    Eur J Pharm Sci; 2015 Jun; 73():44-8. PubMed ID: 25835791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
    AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S; Newton JM; Bloor JR; Hayes G
    Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scale-up of the rounding process in pelletization by extrusion-spheronization.
    Evers M; Weis D; Antonyuk S; Thommes M
    Pharm Dev Technol; 2019 Oct; 24(8):1014-1020. PubMed ID: 31232624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and physicochemical characterization of matrix pellets containing APIs with different solubility via extrusion process.
    Hegyesi D; Thommes M; Kleinebudde P; Sovány T; Kása P; Kelemen A; Pintye-Hódi K; Regdon G
    Drug Dev Ind Pharm; 2017 Mar; 43(3):458-464. PubMed ID: 27838930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.